Pimobendan

Pimobendan

SCHEMBL15617988

COc1ccc(-c2nc3cc(C4=NNC(=O)C[C@H]4C)ccc3[nH]2)cc1

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 6/20 0.84
PDE3A Q14432 6/20 0.84
ABCB11 O95342 1/20 0.84
MAOA P21397 1/20 0.84
ADORA2A P29274 1/20 0.84
GPR119 Q8TDV5 9/20 0.61
PDE4A P27815 2/20 0.58
PDE4B Q07343 2/20 0.58
PDE4C Q08493 2/20 0.58
PDE4D Q08499 2/20 0.58
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
F10 P00742 1/20 0.54
NPC1 O15118 1/20 0.48
PKM P14618 1/20 0.48
RAB9A P51151 1/20 0.48
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pimobendan SCHEMBL14815175 1.00 PDE3B (0.84) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL29386190 1.00 PDE3B (0.84) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL27623 1.00 PDE3B (0.84) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL2466855 1.00 PDE3B (0.84) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL668129 0.99 PDE3B (0.83) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL1996787 0.99 PDE3B (0.83) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL1997246 0.98 PDE3B (0.81) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL1993626 0.95 PDE3B (0.77) PDE3BPDE3AABCB11MAOAADORA2A
Pimobendan SCHEMBL1649737 0.92 PDE3B (1.00) PDE3BPDE3AABCB11MAOAADORA2A
SCHEMBL9781454 0.87 PDE3B (0.64) PDE3BPDE3AABCB11MAOAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118791396-A Preparation method of pimobendan key intermediate and catalyst used in preparation method 江苏天和制药有限公司 2024-10-18 CN disclosed
CN-109568253-B Liquid preparation 罗达制药有限公司 2022-04-26 CN disclosed
US-8680101-B2 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use EUROVET ANIMAL HEALTH B.V. (NL) 2014-03-25 US disclosed